Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia Clinical research trials and Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia. Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.

Home > "O" Clinical Trials Conditions > Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia



Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia

For Condition: Schizoaffective Disorder,Depression,Schizophrenia
Status: Completed
Sponsor(s): Eli Lilly and Company ,
Synopsis: This is a research study comparing the safety and efficacy of two active study medications
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Male or female subjects 18-60 years of age - Female subjects of childbearing potential must be using a medically accepted means of contraception - Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol - Subjects must be considered reliable Exclusion Criteria: - Treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry - Female subjects who are either pregnant or nursing - Uncorrected hypothyroidism or hyperthyroidism - Narrow-angle glaucoma
Total Enrollment: 378

Location and Contact Information:


Additional Information:
Study ID Numbers:
  5529; 
Study Start Date: September 2001
Record last reviewed: May 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00034801

Other Schizophrenia Studies:
1. The Efficacy and Safety of Risperidone in the Treatment of Adolescents with Schizophrenia

2. Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

3. Effects of Modafinil on Brain Function in Patients with Schizophrenia

4. Safety and efficacy of study drug versus placebo for negative symptoms of schizophrenia

5. Extended Release OROS Paliperidone in treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)

Related Studies:

Other Schizophrenia Clinical Trials
Other Texas Clinical Trials
Other Austin Clinical Trials

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia

Modify your Search

  Other Schizophrenia Clinical Trials
  Other Texas Clinical Trials
  Other Austin Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103